$ARNA News Arena shares surge as marketer doubles sales

New Post Public Reply Private Reply Replies (0) Message Board

Nov 30, 2013 at 1:00 AM

$ARNA News

Arena shares surge as marketer doubles sales force for diet drug 11:41 a.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 12:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 1:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 1:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 9:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 9:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 6:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 6:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 7:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 12:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 11:07 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 7:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 7:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 12:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 1:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 3:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 2:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 9:32 a.m. July 30, 2012 - Val Brickates Kennedy
Apple, Arena active; Lumber Liquidators at new high 9:06 a.m. July 25, 2012 - blogs.marketwatch.com

Contrave Data is Positive for Orexigen's Other Weight-Loss Candidate - Analyst 1:08 p.m. Nov. 27, 2013 - Seeking Alpha
ARNA January 2014 Options Begin Trading 10:53 a.m. Nov. 27, 2013 - TheStreet.com
Orexigen Sees Positive Interim Results On Drug Study 1:18 a.m. Nov. 26, 2013 - Seeking Alpha
Arena's Belviq Prescription Data - Week 23 1:28 p.m. Nov. 25, 2013 - Seeking Alpha
Orexigen to Seek FDA Approval for Contrave 12:43 p.m. Nov. 25, 2013 - WSJ.com
3 Monday Morning Biotech Movers 12:15 p.m. Nov. 25, 2013 - Wall St. Cheat Sheet
Investors Put Greater Weight Behind Orexigen Than Arena, Vivus 12:10 p.m. Nov. 25, 2013 - TheStreet.com
Orexigen Weight-Loss Pill Passes Safety Hurdle 7:41 a.m. Nov. 25, 2013 - TheStreet.com
December 27th Options Now Available For Arena Pharmaceuticals (ARNA) 11:02 a.m. Nov. 21, 2013 - TheStreet.com
Interesting ARNA Put And Call Options For July 2014 12:02 p.m. Nov. 19, 2013 - TheStreet.com
(ARNA) Initiated with a Buy, (ICLD, FONR) Strong Performance on Financial Results 1:11 p.m. Nov. 16, 2013 - GuruFocus.com
Apple’s Smartphone Share Declines, JPMorgan’s Chinese Debacle, and 3 More Hot Stocks 1:08 p.m. Nov. 15, 2013 - Wall St. Cheat Sheet
Benzinga's Top #PreMarket Gainers 7:16 a.m. Nov. 15, 2013 - benzinga.com
ARNA December 13th Options Begin Trading 10:53 a.m. Nov. 14, 2013 - TheStreet.com
Arena Expands Marketing Of Obesity Drug To Help Shrink Waistlines 5:00 p.m. Nov. 12, 2013 - TheStreet.com
10-Q: ARENA PHARMACEUTICALS INC 3:52 p.m. Nov. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
Jim Cramer: Buy Apple, Sell AMD, and 2 More Stock Picks 12:05 p.m. Nov. 12, 2013 - Wall St. Cheat Sheet
Arena Pharmaceuticals (ARNA) Worth a Look: Stock Surges 10.6% - Tale of the Tape 8:44 a.m. Nov. 12, 2013 - Zacks.com
Cramer's Lightning Round - Don't Back Away From The Hottest Stock In The Universe (11/11/13) 6:03 a.m. Nov. 12, 2013 - Seeking Alpha
'Mad Money' Lightning Round: 6:00 a.m. Nov. 12, 2013 - TheStreet.com

Promising Partnerships, Stock Price Updates and Participation in Upcoming Healthcare Conferences - Research Report on Quest Diagnostics, Cigna, Arena, Theravance, and Volcano 8:00 a.m. Nov. 29, 2013 - PR Newswire
Arena Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference 8:00 a.m. Nov. 27, 2013 - PR Newswire
Trend Analysis Scan: Synovus Financial, Arena Pharmaceuticals, Facebook Inc, J.C. Penney Company, Citigroup 8:49 a.m. Nov. 26, 2013 - PR Newswire
Early Briefing and Review: Arena Pharma Inc., Geron Corp., Incyte Corp., and Spectrum Pharma Inc. 1:31 p.m. Nov. 22, 2013 - PR Newswire
Health Care Initiatives, Clinical Data Presentations, Public Offerings, Contract Extensions and Publication of Pre-Clinical Study - Research Report on Cigna, Arena, Synta, Healthways, and Catalyst 8:00 a.m. Nov. 21, 2013 - PR Newswire
BELVIQ® (lorcaserin HCl) CIV Data to be Presented at American Heart Association 2013 Scientific Sessions 8:00 a.m. Nov. 18, 2013 - PR Newswire
BELVIQ® (lorcaserin HCl) CIV Data Featured in Five Abstracts to be Presented at ObesityWeek(SM) 2013 4:05 p.m. Nov. 13, 2013 - PR Newswire
Biotechnology Companies' Quarterly Results - Research Report on Geron, Santarus, Merrimack, Clovis, and Arena 8:00 a.m. Nov. 12, 2013 - PR Newswire
GOGO, CLDX, VPHM and ARNA Added to NASDAQ Active Stock Watch List at EPR 10:14 a.m. Nov. 11, 2013 - ACCESSWIRE
TrendingWallStreet.com Initiates Research on EGY, GLER, PGLO, and ARNA 12:16 a.m. Nov. 11, 2013 - ACCESSWIRE
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results 4:10 p.m. Nov. 7, 2013 - PR Newswire
Arena Pharmaceuticals and Eisai Expand Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) to Include Most Countries Worldwide 4:02 p.m. Nov. 7, 2013 - PR Newswire
FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech 8:00 a.m. Nov. 7, 2013 - PR Newswire
Must Watch Stock News: Arena Pharmaceuticals, Hewlett-Packard Company, Resorts International, Alpha Natural Resources, Chevron Corporation 1:56 p.m. Nov. 4, 2013 - PR Newswire
Pre-Market Review: Arena Pharma Inc., Geron Corp., Incyte Corp. Ltd, and Spectrum Pharma Inc. 9:00 a.m. Oct. 31, 2013 - PR Newswire
Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7 8:00 a.m. Oct. 30, 2013 - PR Newswire
Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros 8:00 a.m. Oct. 21, 2013 - PR Newswire
Arena Pharmaceuticals Reports That Eisai Will Double BELVIQ® (lorcaserin HCl) CIV Sales Force by December 9:03 a.m. Oct. 15, 2013 - PR Newswire
Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp. 9:26 a.m. Oct. 8, 2013 - PR Newswire
Drug Approvals, Data Presentations, Conferences, Increased Funding, and Merger Agreements - Research Report on Theravance, Arena, Exelixis, Verenium, and Enanta 8:00 a.m. Sept. 25, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Peptide Therapy Rules Change: Gameday Ups the Ante

Gameday Men's Health: Leading the Safe Peptide Charge Finally, we got some regulatory sanity stepping up to the plate with peptides. You see, the FDA's new interim policy is letting state-licensed compounding pharmacies work their magic with peptides, but only under strict medical watch. And Gameday Men's Health sure ain't wasting any time setting up shop in this fresh...

Markel's Reinsurance Shift with $4.8B Deal: Strategic Move?

Weaving Through Complex Insurance Terrain When Markel Insurance pulls a move on the chessboard that involves $4.8 billion in subject reserves, we better pay attention. The insurance bigwig has inked a reinsurance deal with Enstar. This plan, they say, will help them focus more on their specialty insurance game while tidying up the loose ends in their global reinsurance...

Hollywood Vampires' Limited Art Sparks Las Vegas Buzz

A Collaboration to Captivate Art and Rock Enthusiasts When it comes to mixing rock and roll with fine art, Markus Klinko's exclusive photograph featuring the Hollywood Vampires hits the nail on the head. It’s not just an image; it’s a slice of modern rock history immortalized on paper. This new release, a portrait capturing the raw passion of Alice Cooper, Johnny...

?atwogang Leads Tiltify's Impact Creator Class of 2026

Charity Meets Creativity: A New Era Unveiled Who would have thought? Charitable fundraising is no longer just about writing checks. It's about creativity, community, and leveraging tech to drive change. Enter Tiltify's Creator Impact Class of 2026—proof that we're living in a brave new world where internet creators are the kings and queens of giving. ?atwogang Takes...

Alchemy's Texas Move: Strategic Growth or Gamble?

Making a Splash in Texas IT Services Alchemy Technology Group's acquisition of Freeit Data Solutions isn't just another drop in the tech pond; it's a cannonball aimed at shaking up the IT and cybersecurity scenes in Texas. By bringing Freeit's impressive 16-year track record under its wing, Alchemy is flexing its muscles in a region already bustling with IT infrastructure...

Group 1 Automotive Q3 2026: Profits Soar, Revenues Dip

Profits Up, Revenues Down Here's a tale for the books—Group 1 Automotive reports their third quarter results of 2026 and it's a bit like swapping a thunderstorm for a hurricane. Net income from continuing operations stomped on last year's figures, clocking in at a hefty $102.9 million compared to a skimpy $13.1 million. But don't let that fool you, their total revenues...

Lilly's Retatrutide Outshines Ozempic in Key Diabetes Trial

Lilly's Breakthrough in Diabetes Treatment Eli Lilly's retatrutide is stirring up the diabetes treatment waters. The latest Phase 3 comparison to Ozempic's top dose reveals some surprising results. I'm not one to toss out kudos lightly, but this could be a genuine game-changer if things hold steady. A1C Reductions: A Close Look at the Numbers We’re staring down the...

Miracle League Marks Two Decades with Big Fundraising Win

A Double Decade Celebration of Dream and Dedication The Miracle League of the Triangle sure knows how to throw a party—for them, it's not just a gala; it's a testament to two decades of turning dreams into reality. On October 13th, over 300 guests gathered at the Angus Barn Pavilion in Cary, NC, proving that passion for inclusive baseball is just as alive as it was 20...

Palmdale Propane Expands with Affordable Gas Buy

Propane Power Play in Florida's Market Here's a little tune you don't hear every day: two local businesses tangoing to the beat of expansion without making a public peep about the price. Palmdale Propane, a powerhouse under the Palmdale Oil umbrella, just snapped up Affordable Gas, a local player from Belle Glade, Florida. This acquisition strengthens its grip on the...

Northeast Indiana Bancorp Shows Solid Third Quarter Gains

Holding Steady in a Shaky Market In a market often rocked by turbulence, it seems Northeast Indiana Bancorp, Inc. has found a decent footing to stand on. Announcing their third-quarter results for 2026, they’ve posted net income of $1.991 million, showcasing a neat jump from the $1.793 million in the same period last year. Not bad at all for the parent company of First...